As a greater number of drugs are distributed through specialty channels, it is difficult to gain deep insights into the patient journey. Single data sources provide limited visibility…

A top 20 pharma company noticed that a significant portion of patients who were on an infusion therapy had stopped treatment. This happened despite patients receiving support through…

A major pharma company had developed a treatment for a rare condition. However, two years after launch, the drug’s sales were far below expectations. Finding eligible patients for…

Address the need for highly accurate privacy-preserving record linkage and patient matching solutions to unlock research and innovation.

Connecting data at the patient level is critical in gaining a deep, longitudinal view of how different interventions and policies can affect patient outcomes. The following peer-reviewed articles…

As more patient data comes online each year, there is a need to ensure these new datasets are assessed for disclosure risk and adequately de-identified to protect patient…

Given the intense focus on the development of COVID-19 vaccines, clinical trials emerged at the forefront of the national conversation. This also brought increased interest in “Decentralized Clinical…

By virtue of sheer volume, oncology trials can set the stage for overall clinical trial innovation. Moreover, oncology as a therapeutic area has seen the closest interplay between…